Tae, H. S., Ortells, M. O., Yousuf, A., Xu, S. Q., Akk, G., Adams, D. J., & Arias, H. R. (2024). Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel. Web
Citación estilo ChicagoTae, Han Shen, Marcelo Oscar Ortells, Arsalan Yousuf, Sophia Q. Xu, Gustav Akk, David J. Adams, and Hugo Rubén Arias. Tabernanthalog and Ibogainalog Inhibit the α7 and α9α10 Nicotinic Acetylcholine Receptors Via Different Mechanisms and With Higher Potency Than the GABAA Receptor and CaV2.2 Channel. 2024.
Cita MLATae, Han Shen, et al. Tabernanthalog and Ibogainalog Inhibit the α7 and α9α10 Nicotinic Acetylcholine Receptors Via Different Mechanisms and With Higher Potency Than the GABAA Receptor and CaV2.2 Channel. 2024.